Guardant Health announced an almost $100M Series D round for its cancer blood test
The Redwood City, Calif.-based company has raised nearly $100 million in Series D financing led by OrbiMed Advisors.
The Redwood City, Calif.-based company has raised nearly $100 million in Series D financing led by OrbiMed Advisors.